, Cancer Journal
M Carré 7 , M-A Couturier 8 , E Daguindau 9 , J-P Marolleau 10 , F Orsini-Piocelle 11, J Delaunay LM Fornecker, vol.1, issue.25 1 21 ,
,
,
,
,
,
,
,
, Hôpital Augustin Morvan
,
,
,
,
, , p.17
,
,
,
, Hématologie Clinique, vol.21, issue.22
, , p.24
,
, Nantes, vol.1035
High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia, New England Journal of Medicine, vol.361, issue.13, pp.1235-1248, 2009. ,
DOI : 10.1056/NEJMoa0901409
Addition of Lomustine to Idarubicin and Cytarabine Improves the Outcome of Elderly Patients With De Novo Acute Myeloid Leukemia: A Report From the GOELAMS, Journal of Clinical Oncology, vol.28, issue.18, pp.3028-3034, 2010. ,
DOI : 10.1200/JCO.2009.26.4648
URL : https://hal.archives-ouvertes.fr/hal-00849638
Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia???a wise Liaison?, Leukemia, vol.118, issue.9, pp.1813-1819, 2013. ,
DOI : 10.1056/NEJMoa1013343
Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study, Leukemia, vol.29, issue.6, pp.1403-1407, 2013. ,
DOI : 10.1200/JCO.2010.31.8576
Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes, Blood, vol.120, issue.25, pp.4945-4951, 2012. ,
DOI : 10.1182/blood-2012-06-434639
Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia, Leukemia, vol.72, issue.5, pp.893-901, 2012. ,
DOI : 10.1046/j.0902-4441.2003.00184.x
A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML, Leukemia, vol.27, issue.3, pp.725-728, 2013. ,
DOI : 10.1200/JCO.2004.99.116
Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia, Haematologica, vol.98, issue.4, pp.591-596, 2013. ,
DOI : 10.3324/haematol.2012.076414
Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome, Leukemia & Lymphoma, vol.94, issue.3, pp.1-7, 2015. ,
DOI : 10.1038/leu.2013.58
Sequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia: a single-arm, phase 1/2 study, The Lancet Haematology, vol.2, issue.1, pp.12-20, 2015. ,
DOI : 10.1016/S2352-3026(14)00026-X
Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML), Annals of Hematology, vol.25, issue.5, pp.47-55, 2014. ,
DOI : 10.1038/leu.2011.9
A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission, Leukemia, vol.26, issue.11, pp.2428-2431, 2014. ,
DOI : 10.1182/blood-2009-03-211003
Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503), Leukemia, vol.3, issue.1, pp.34-39, 2017. ,
DOI : 10.1158/0008-5472.CAN-04-4532
Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia, British Journal of Haematology, vol.110, issue.2, pp.199-210, 2015. ,
DOI : 10.1002/cncr.23112
Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study, Journal of Clinical Oncology, vol.35, issue.4, pp.387-393, 2017. ,
DOI : 10.1200/JCO.2016.67.6213
URL : https://hal.archives-ouvertes.fr/hal-01529184
, International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license